PharmaCyte Biotech, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PMCB Nasdaq 2836 pharmacyte.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for PharmaCyte Biotech, Inc.

BC-Most Active Stocks - Dec 4th, 2025 8:30 am
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Nov 25th, 2025 7:15 am
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing - Aug 20th, 2025 7:15 am
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Aug 18th, 2025 7:15 am
Top Penny Stocks To Watch In February 2025 - Feb 26th, 2025 4:04 am